ANG Lifesciences India
Ang Lifesciences India Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in ANG Lifesciences India
Start SIPAng Lifesciences India Investment Rating
-
Master Rating:
-
Angel One has an operating revenue of Rs. 3,399.62 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 40% is great, ROE of 41% is exceptional. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 71% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 96 which is a GREAT score indicating consistency in earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Finance-Investment Mgmt and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 30 | 51 | 32 | 45 | 58 | 72 | 96 |
Operating Expenses Qtr Cr | 28 | 45 | 43 | 43 | 44 | 60 | 84 |
Operating Profit Qtr Cr | 1 | 6 | -12 | 2 | 14 | 11 | 12 |
Depreciation Qtr Cr | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
Interest Qtr Cr | 2 | 2 | 1 | 3 | 3 | 3 | 4 |
Tax Qtr Cr | 0 | 1 | -1 | -1 | 2 | 3 | 2 |
Net Profit Qtr Cr | -2 | 2 | -5 | -2 | 8 | 3 | 5 |
Ang Lifesciences India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹65.49
- 50 Day
- ₹67.51
- 100 Day
- ₹70.29
- 200 Day
- ₹81.64
- 20 Day
- ₹65.04
- 50 Day
- ₹68.31
- 100 Day
- ₹69.37
- 200 Day
- ₹73.72
Ang Lifesciences India Resistance and Support
Resistance | |
---|---|
First Resistance | 67.68 |
Second Resistance | 69.80 |
Third Resistance | 71.61 |
RSI | 47.87 |
MFI | 49.15 |
MACD Single Line | -1.32 |
MACD | -1.00 |
Support | |
---|---|
First Resistance | 63.75 |
Second Resistance | 61.94 |
Third Resistance | 59.82 |
Ang Lifesciences India Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 18,679 | 1,270,359 | 68.01 |
Week | 12,201 | 709,976 | 58.19 |
1 Month | 14,991 | 991,371 | 66.13 |
6 Month | 16,356 | 1,143,763 | 69.93 |
Ang Lifesciences India Result Highlights
ANG Lifesciences India Synopsis
NSE-Finance-Investment Mgmt
Angel One belongs to the Industry of Finance & Investments. Company’s Total Operating Revenue is Rs. 2984.08 Cr. and Equity Capital is Rs. 83.42 Cr. for the Year ended 31/03/2023. Angel One Ltd. is a Public Limited Listed company incorporated on 08/08/1996 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L67120MH1996PLC101709 and registration number is 101709.Market Cap | 25,008 |
Sales | 3,381 |
Shares in Float | 5.20 |
No of funds | 193 |
Yield | 1.07 |
Book Value | 11.77 |
U/D Vol ratio | 1.2 |
LTDebt / Equity | 1 |
Alpha | 0.25 |
Beta | 1.15 |
ANG Lifesciences India
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 38.26% | 38.3% | 38.48% | 43.68% |
Mutual Funds | 8.15% | 8.28% | 8% | 7.71% |
Insurance Companies | 0.73% | 0.43% | 0.57% | 0.45% |
Foreign Portfolio Investors | 16.4% | 14.35% | 13.31% | 13.95% |
Individual Investors | 31.11% | 31.4% | 32.7% | 27.09% |
Others | 5.35% | 7.24% | 6.94% | 7.12% |
ANG Lifesciences India Management
Name | Designation |
---|---|
Mr. Dinesh D Thakkar | Chairman & Managing Director |
Mr. Ketan Shah | Whole Time Director |
Mr. Krishna Iyer | Non Executive Director |
Ms. Mala Todarwal | Ind. Non-Executive Director |
Mr. Muralidharan Ramachandran | Ind. Non-Executive Director |
Mr. Krishnaswamy Arabadi Sridhar | Ind. Non-Executive Director |
Mr. Kalyan Prasath | Ind. Non-Executive Director |
Ang Lifesciences India Forecast
Price Estimates
Ang Lifesciences India Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-14 | Quarterly Results | |
2023-08-14 | Quarterly Results | |
2023-05-30 | Audited Results | |
2023-03-06 | Preferential issue of shares | |
2023-02-14 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2021-11-04 | INTERIM | Rs.1.00 per share(10%)Interim Dividend |
Date | Purpose | Remarks |
---|---|---|
2022-07-14 | Bonus | Rs.0.00 issue in the ratio of 1:4 of Rs. 10/- |
2021-09-23 | Bonus | Rs.0.00 issue in the ratio of 1:1 of Rs. 10/- |
ANG Lifesciences India FAQs
What is Share Price of ANG Lifesciences India ?
ANG Lifesciences India share price is ₹65 As on 11 December, 2023 | 23:38
What is the Market Cap of ANG Lifesciences India ?
The Market Cap of ANG Lifesciences India is ₹84.9 Cr As on 11 December, 2023 | 23:38
What is the P/E ratio of ANG Lifesciences India ?
The P/E ratio of ANG Lifesciences India is -12.2 As on 11 December, 2023 | 23:38
What is the PB ratio of ANG Lifesciences India ?
The PB ratio of ANG Lifesciences India is 1 As on 11 December, 2023 | 23:38